Bio-Works Technologies
Bio-Works Receives New Orders for Custom GoBio Columns for the U.S. Gene Therapy Market
The ordered product is a unique version of GoBio, developed specifically for plasmid purification – a key component in the production of viral vectors for gene therapy. By tailoring the solution, the customer has achieved results that wouldn’t have been possible with a standard product.
“We see a clear trend where more customers are recognizing the value of customized purification solutions to optimize their processes. This is where Bio-Works is well positioned to contribute,” says Lone Carlbom, CEO of Bio-Works.
“Our strength lies in the combination of technical expertise and flexibility, allowing us to quickly develop niche products with real impact. At the same time, it strengthens our product portfolio and opens doors to more customers with similar needs. It’s a win-win.”
GoBio is Bio-Works’ line of pre-packed columns – a growing product segment in the so-called “plug and play” category. These turnkey solutions eliminate the need for manual column packing, saving both time and resources for the user.
This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014) and the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 27-03-2025 16:02 CET.
| Datum | 2025-03-27, kl 16:02 |
| Källa | Cision |
Alla Aktier tipsar: Har du redan ett konto på Avanza? Varför inte skapa ett på Nordnet också och jämföra funktioner, courtage mm. Det tar inte lång tid, du fixar det direkt här med BankID